Principal Financial Group’s DICE Therapeutics DICE Stock Holding History
Bought
Maintained
Sold
Principal Financial Group's DICE Position: Q3 2023 in Review
Principal Financial Group sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 10,976 shares — an estimated $510K sold.
Principal Financial Group first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $510K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Principal Financial Group reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
- Principal Financial Group sold 10,976 DICE Therapeutics shares in Q3 2023, an estimated $510K.
- Principal Financial Group first reported a position in DICE Therapeutics in Q4 2022 and held it in 3 quarters.
- Principal Financial Group's DICE Therapeutics position peaked at $510K in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.
Based on Principal Financial Group's 13F filing for Q3 2023, filed 2 Nov 2023.